Author
Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals.
The corporation, with its asset base touching Rs 93,241 crore, and its sales and profit at Rs 1,88,651 crore and Rs 8,463 crore respectively, is in the top 10 of BW Real 500 again
Read MoreFamily run businesses still dominate corporate India, but many are now opting to let professionals run the show
Read MoreDifferent bodies have different needs — from nutrients to medicines. That’s where the future of healthcare is
Read MoreReason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed
Read MoreThe Indian government by virtue of its majority ownership in public sector companies, including banks and oil marketers, has become richer by Rs 1,44,637 crore in 2016 compared to the previous year
Read MoreCurbs on exchange of old currency and the ‘black money haven’ tag have stalled the cooperative banking sector
Read MoreThe Tata-Mistry battle has now percolated down to the boardrooms of group companies, portending mayhem
Read MoreDiageo, the world’s largest spirit and alcoholic beverages company, wants to transform the practices in Indian market
Read MoreJSC is currently engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region mainly focusing on the hospital segment had annual revenues of approximately $ 52 million in 2015
Read MorePredictive sales analytics start-up Vymo said on Tuesday (22 Oct.) that it has raised $5 million Series A fund from Sequoia India
Read More